246
Views
33
CrossRef citations to date
0
Altmetric
Letters

Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease

, , , , , , , , , , , & show all
Pages 156-158 | Accepted 22 Nov 2011, Published online: 15 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Yuko Kaneko & Tsutomu Takeuchi. (2022) Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still’s disease. Expert Opinion on Biological Therapy 22:1, pages 79-85.
Read now
Dae Hyun Yoo. (2019) Biologics for the treatment of adult-onset still’s disease. Expert Opinion on Biological Therapy 19:11, pages 1173-1190.
Read now
Ju-Yang Jung, Chang-Hee Suh & Hyoun-Ah Kim. (2019) The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still’s disease. Expert Review of Molecular Diagnostics 19:6, pages 459-468.
Read now
Piero Ruscitti & Roberto Giacomelli. (2018) Pathogenesis of adult onset still’s disease: current understanding and new insights. Expert Review of Clinical Immunology 14:11, pages 965-976.
Read now
Dae Hyun Yoo. (2017) Treatment of adult-onset still’s disease: up to date. Expert Review of Clinical Immunology 13:9, pages 849-866.
Read now
Hyoun-Ah Kim & Chang-Hee Suh. (2017) An update: current and prospective treatments for adult-onset Still’s disease. Expert Opinion on Orphan Drugs 5:5, pages 421-429.
Read now
Akiko Komiya, Toshihiro Matsui, Koichiro Horie, Hidefumi Fukuda, Kanako Iwata, Hirotaka Tsuno, Hideki Ogihara, Tatsuoh Ikenaka, Misato Kawakami, Hiroshi Furukawa, Atsushi Hashimoto, Kotaro Hirai & Shigeto Tohma. (2016) Neutrophil CD64 is upregulated in RA patients with lymphoma but not in other solid cancers. Modern Rheumatology 26:2, pages 216-223.
Read now

Articles from other publishers (26)

Xinglan He, Ruixuan You, Yaqian Shi, Zhuotong Zeng, Bingsi Tang, Jiangfan Yu, Yangfan Xiao & Rong Xiao. (2023) Pyroptosis: the potential eye of the storm in adult-onset Still’s disease. Inflammopharmacology.
Crossref
N. L. M. van de Ven, S. H. Bongers, R. Spijkerman, L. Koenderman, L. P. H. Leenen, F. Hietbrink, Thomas M. P. Nijdam, Bas J. J. Bindels, Nikita K. N. Jorritsma, Remi Verhaegh, Judith S. Spanjaard, Benjamin W. Verboeket, Duco Laane, Karlijn van Wessem, Wiebe Buitenwerf, Daan E. J. van Spengler, Eva Mulder, Nienke Vrisekoop, Harry Heijerma, Harriët M. R. van Goor, Amely Daza Zabaleta, Frederiek van den Bos, Feikje Stiphout, Karin A. H. Kaasjager, Emma Rademaker, Meri R. J. Varkila, Nikki de Mul, Olaf L. Cremer, Arjen Slooter, Maarten Limper, Helen Leavis, Eveline M. Delemarre, Aridaman Pandit, Femke van Wijk, Stefan Nierkens, Bernard N. Jukema, Chantal C. Clark, Arjan D. Barendrecht, Cor W. Seinen, Sandra Drost-Verhoef, Simone Smits, Naomi M. J. Parr, Sylvie A. E. Sebastian, Arnold C. Koekman, Annet C. van Wesel, Erhard van der Vries, Coen Maas, Steven de Maat, Saskia Haitjema, Imo E. Hoefer, Gerjen H. Tinnevelt & Jeroen J. Jansen. (2023) Point-of-care neutrophil CD64 as a rule in diagnostic test for bacterial infections in the emergency department. BMC Emergency Medicine 23:1.
Crossref
Stefan Vordenbäumen, Eugen Feist, Jürgen Rech, Martin Fleck, Norbert Blank, Johannes-Peter Haas, Ina Kötter, Martin Krusche, Gamal Chehab, Bimba Hoyer, Uta Kiltz, Dorothea Fell, Julia Reiners, Christiane Weseloh, Matthias Schneider & Jürgen Braun. (2022) Diagnosis and treatment of adult-onset Still’s disease: a concise summary of the German society of rheumatology S2 guidelineDiagnostik und Behandlung bei M. Still des Erwachsenen: kurze Zusammenfassung der S2-Leitlinie der Deutschen Gesellschaft für Rheumatologie. Zeitschrift für Rheumatologie 82:S2, pages 81-92.
Crossref
Fumiaki Kondo, Takahiko Sugihara, Natsuka Umezawa, Hisanori Hasegawa, Tadashi Hosoya, Naoki Kimura, Masaaki Mori & Shinsuke Yasuda. (2022) Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still’s disease. Arthritis Research & Therapy 24:1.
Crossref
Stefan Vordenbäumen, Eugen Feist, Jürgen Rech, Martin Fleck, Norbert Blank, Johannes-Peter Haas, Ina Kötter, Martin Krusche, Gamal Chehab, Bimba Hoyer, Uta Kiltz, Dorothea Fell, Julia Reiners, Christiane Weseloh, Matthias Schneider & Jürgen Braun. (2022) DGRh-S2e-LeitlinieDGRh S2e guidelines. Zeitschrift für Rheumatologie 81:S1, pages 1-20.
Crossref
Shijia Rao, Lemuel Shui-Lun Tsang, Ming Zhao, Wei Shi & Qianjin Lu. (2022) Adult-onset Still’s disease: A disease at the crossroad of innate immunity and autoimmunity. Frontiers in Medicine 9.
Crossref
Bert Malengier-Devlies, Mieke Metzemaekers, Carine Wouters, Paul Proost & Patrick Matthys. (2021) Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis. Frontiers in Immunology 12.
Crossref
Ji-Won Kim, Mi-Hyun Ahn, Ju-Yang Jung, Chang-Hee Suh & Hyoun-Ah Kim. (2021) An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease. International Journal of Molecular Sciences 22:23, pages 13038.
Crossref
Piero Ruscitti, Onorina Berardicurti, Roberto Giacomelli & Paola Cipriani. (2021) The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients. Seminars in Immunology 58, pages 101632.
Crossref
Yasuhiro Shimojima, Takanori Ichikawa, Dai Kishida, Ryota Takamatsu & Yoshiki Sekijima. (2021) Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability. Clinical and Experimental Immunology 206:2, pages 184-195.
Crossref
Takanori Ichikawa, Yasuhiro Shimojima, Dai Kishida, Ken‐ichi Ueno & Yoshiki Sekijima. (2021) The implication of interferon‐γ‐producing immunocompetent cells for evaluating disease activity and severity in adult‐onset Still’s disease. International Journal of Rheumatic Diseases 24:9, pages 1176-1185.
Crossref
Ju-Yang Jung, Ji-Won Kim, Chang-Hee Suh & Hyoun-Ah Kim. (2020) Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease. Frontiers in Immunology 11.
Crossref
Takashi Shimizu, Akie Kikuchi-Taura, Soichiro Tsuji, Masato Matsushita, Shiro Ohshima & Yukihiko Saeki. (2020) Up-regulation of CD64 Expression on Monocytes in Patients With Active Adult-Onset Still Disease. JCR: Journal of Clinical Rheumatology 26:2, pages 67-72.
Crossref
Meng-Yan Wang, Jin-Chao Jia, Cheng-De Yang & Qiong-Yi Hu. (2019) Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review. Chinese Medical Journal 132:23, pages 2856-2864.
Crossref
Yasuhiro Shimojima, Dai Kishida, Ken-ichi Ueno, Satoru Ushiyama, Takanori Ichikawa & Yoshiki Sekijima. (2019) Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease. The Journal of Rheumatology 46:10, pages 1268-1276.
Crossref
Shinichi Nogi, Yoshiyuki Arinuma, Akiko Komiya, Atsushi Hashimoto, Toshihiro Matsui & Shigeto Tohma. (2018) Clinical Utility of Neutrophil CD64 to Detect Extrapulmonary Tuberculosis in Three Patients with Rheumatoid Arthritis Undergoing Treatment with Biologics. Case Reports in Rheumatology 2018, pages 1-6.
Crossref
Roberto Giacomelli, Piero Ruscitti & Yehuda Shoenfeld. (2018) A comprehensive review on adult onset Still's disease. Journal of Autoimmunity 93, pages 24-36.
Crossref
Paolo Sfriso, Sara Bindoli & Paola Galozzi. (2018) Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances. Drugs 78:12, pages 1187-1195.
Crossref
Nienke M. ter Haar, Tamar Tak, Michal Mokry, Rianne C. Scholman, Jenny M. Meerding, Wilco de Jager, Anouk Verwoerd, Dirk Foell, Thomas Vogl, Johannes Roth, Pieter H. C. Leliefeld, Jorg van Loosdregt, Leo Koenderman, Sebastiaan J. Vastert & Sytze de Roock. (2018) Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis. Arthritis & Rheumatology 70:6, pages 943-956.
Crossref
Zdeněk Adam, Jana Skřičková, Milan Krtička, Zdeněk Řehák, Renata Koukalová, Andrea Šprláková, Marta Krejčí, Luděk Pour, Zdenka Adamová, Eva Pourová & Zdeněk Král. (2017) Remission of steroid-resistant Still's disease treated with anakinra, evidenced by FDG-PET/CT examination: case report. Vnitřní lékařství 63:12, pages 987-997.
Crossref
Rajesh Gopalarathinam, Eric Orlowsky, Ramesh Kesavalu & Sreeteja Yelaminchili. (2016) Adult Onset Still’s Disease: A Review on Diagnostic Workup and Treatment Options. Case Reports in Rheumatology 2016, pages 1-6.
Crossref
M. Gerfaud-Valentin, P. Sève, A. Hot, C. Broussolle & Y. Jamilloux. (2015) Données actualisées sur la physiopathologie, les phénotypes et les traitements de la maladie de Still de l’adulte. La Revue de Médecine Interne 36:5, pages 319-327.
Crossref
Yvan Jamilloux, Mathieu Gerfaud-Valentin, Fabio Martinon, Alexandre Belot, Thomas Henry & Pascal Sève. (2014) Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart. Immunologic Research 61:1-2, pages 53-62.
Crossref
Mathieu Gerfaud-Valentin, Yvan Jamilloux, Jean Iwaz & Pascal Sève. (2014) Adult-onset Still's disease. Autoimmunity Reviews 13:7, pages 708-722.
Crossref
Weng Seng Fong & Nai Lee Lui. (2013) Adult-Onset Still's Disease: A Review. Proceedings of Singapore Healthcare 22:1, pages 40-47.
Crossref
Clio P. Mavragani, Evangelos G. Spyridakis & Michael Koutsilieris. (2012) Adult-Onset Still’s Disease: From Pathophysiology to Targeted Therapies. International Journal of Inflammation 2012, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.